newsfilter
← Latest News
GlobeNewswire·

MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO

CHICAGO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer,